CClinicalTrials.gg
CompletedNCT06432933OXYBARUpdated Jul 18, 2025

Comparison of Apnea-Hypopnea Index in Patients With or Without Preventive Oxygen Therapy After Bariatric Surgery

An interventional study of No preventive oxygen therapy (2L) and Preventive oxygen therapy (2L) standard care in Obstructive Sleep Apnea, Obesity and Bariatric Surgery Candidate, sponsored by Rijnstate Hospital. Completed at 1 site in Netherlands. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-07-18.

Sponsored by Rijnstate Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
153
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The best perioperative strategy for obstructive sleep apnea (OSA) in bariatric surgery remains unclear. A strategy is to monitor patients and administer preventive oxygen therapy during the first postoperative night. However it is unknown what if preventive oxygen therapy is necessary.

The goal of this trial is to compare the Apnea-Hypopnea Index (AHI) in participants with or without preventive oxygen therapy.

Methods:

Participants are patients who underwent bariatric surgery without treated OSA and will be will be randomized into arm A or arm B:

Arm A: First postoperative night in the hospital with preventive oxygen therapy (standard care), Arm B: First postoperative night in hospital without preventive oxygen therapy (intervention).

Read the detailed description

Rationale: The prevalence of obstructive sleep apnea (OSA) in the bariatric surgery population is high and mostly undiagnosed. The best perioperative strategy to manage sleep apnea in bariatric patients remains unclear. A recent study found that monitoring patients with pulsoximetry and giving them preventive oxygen therapy during the first postoperative night is safe and cost effective. In a population with patients with OSA but without obesity, no significant difference in apnea hypopnea index (AHI) was found between patients with and without oxygen therapy during the first postoperative night. The question was raised if preventive oxygen therapy during the first postoperative night after bariatric surgery is needed.

Objective: The primary objective of this study is to compare AHI in patients with potentially undiagnosed OSA, treated with or without preventive oxygen therapy, during the first night after bariatric surgery. The secondary objective of this study is to compare sleep architecture in these patients

Study design: This is a randomized controlled non-inferiority trial consisting of two arms; Arm A: First postoperative night in the hospital with preventive oxygen therapy (standard care), Arm B: First postoperative night in hospital without preventive oxygen therapy (intervention).

Study population: Patients scheduled for primary bariatric surgery without treated OSA Intervention: During the first postoperative night at the hospital patients in intervention arm B will not receive preventive oxygen therapy.

Main study parameters/endpoints: Primary endpoint is AHI and secondary endpoints are 30 days complications rate, nursing intervention rate and parameters for sleep architecture and sleep related breathing, score of the Epworth Sleepiness Scale (ESS) and STOP BANG.

02

Conditions studied

  • Obstructive Sleep Apnea
  • Obesity
  • Bariatric Surgery Candidate
03

In context

Sleep Apnea, Obstructive

2,198 studies on the registry are indexed under Sleep Apnea, Obstructive; 469 are open to participants now.

This study's enrollment of 153 is above the median of 53 across 1,448 interventional studies indexed under Sleep Apnea, Obstructive.

Browse Sleep Apnea, Obstructive studies →

Lead sponsor

Rijnstate Hospital is the lead sponsor of 127 studies on the registry; 14 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Undergo primary bariatric surgery (RYGB or SG)
  • Speak and read the Dutch language

Exclusion criteria

Exclusion Criteria:

  • Revisional bariatric surgery (e.g. sleeve conversion, RYGB after gastric banding)
  • Same-day discharge after bariatric surgery
  • Diagnosed OSA with treatment (CPAP, oral appliances)
  • Professional drivers
  • Use of alpha blockers
  • Unable to speak or read the Dutch language
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
153 participants (actual)

Study arms

  • Experimental
    Without preventive oxygen therapy

    Other: No preventive oxygen therapy (2L)

  • Active comparator
    With preventive oxygentherapy

    Other: Preventive oxygen therapy (2L) standard care

Interventions

  • OtherNo preventive oxygen therapy (2L)

    Participants will not receive preventive oxygen 2L during the first postoperative night after bariatric surgery.

  • OtherPreventive oxygen therapy (2L) standard care

    Participants will receive preventive oxygen 2L during the first postoperative night after bariatric surgery, standard care.

06

What researchers measure

Primary outcomes

  1. Apnea-Hypopnea Index (AHI)

    AHI will be measured by a home sleep study device (Watchpat300) and will be compared between both arms, the higher the AHI the more severe the sleep apnea

    Time frame: First postoperative night

Secondary outcomes

  1. Complication rate

    All complication will be scored and will be compared between both arms

    Time frame: Until 30 days after surgery

  2. The number of nursing interventions

    Nursing interventions will be scored on a form and the number of nursing interventions will be compared between both arms

    Time frame: First postoperative night

  3. Type of nursing interventions

    e.g. waking up the patient or starting or increasing oxygen therapy/flow, this will be compared between both arms.

    Time frame: First postoperative night

  4. Oxygen Desaturation Index (ODI)

    ODI will be measured by a home sleep study device (Watchpat300) and will be compared between both arms

    Time frame: First postoperative night

  5. AHI during Rapid Eye Movement (REM) sleep

    AHI during REM sleep will be measured by a home sleep study device (Watchpat300) and will be compared between both arms

    Time frame: First postoperative night

  6. Respiratory disturbance index (RDI)

    RDI will be measured by a home sleep study device (Watchpat300) and will be compared between both arms

    Time frame: First postoperative night

  7. Mean saturation

    Mean saturation will be measured by a home sleep study device (Watchpat300) and will be compared between both arms

    Time frame: First postoperative night

  8. Mean saturation during desaturations,

    Mean saturation during desaturations will be measured by a home sleep study device (Watchpat300) and will be compared between both arms

    Time frame: First postoperative night

  9. Number of desaturations

    Number of desaturations will be measured by a home sleep study device (Watchpat300) and will be compared between both arms

    Time frame: First postoperative night

  10. Percentage of saturation <90%

    will be measured by a home sleep study device (Watchpat300) and will be compared between both arms

    Time frame: First postoperative night

  11. Percentage of saturation <88%

    will be measured by a home sleep study device (Watchpat300) and will be compared between both arms

    Time frame: First postoperative night

  12. Percentage of saturation <85%

    will be measured by a home sleep study device (Watchpat300) and will be compared between both arms

    Time frame: First postoperative night

  13. Percentage of saturation <80%

    will be measured by a home sleep study device (Watchpat300) and will be compared between both arms

    Time frame: First postoperative night

  14. Percentage of saturation <70%

    will be measured by a home sleep study device (Watchpat300) and will be compared between both arms

    Time frame: First postoperative night

  15. Time (minutes) of saturation <90%

    will be measured by a home sleep study device (Watchpat300) and will be compared between both arms

    Time frame: First postoperative night

  16. Time (minutes) of saturation <88%

    will be measured by a home sleep study device (Watchpat300) and will be compared between both arms

    Time frame: First postoperative night

  17. Time (minutes) of saturation <85%

    will be measured by a home sleep study device (Watchpat300) and will be compared between both arms

    Time frame: First postoperative night

  18. Time (minutes) of saturation <80%

    will be measured by a home sleep study device (Watchpat300) and will be compared between both arms

    Time frame: First postoperative night

  19. Time (minutes) of saturation <70%

    will be measured by a home sleep study device (Watchpat300) and will be compared between both arms

    Time frame: First postoperative night

  20. Total sleep time (minutes)

    Total sleep time will be measured by a home sleep study device (Watchpat300) and will be compared between both arms

    Time frame: First postoperative night

  21. Percentage of REM sleep in total sleep time

    Percentage of REM sleep will be measured by a home sleep study device (Watchpat300) and will be compared between both arms

    Time frame: First postoperative night

  22. Percentage of Deep sleep in total sleep time

    Percentage of Deep sleep will be measured by a home sleep study device (Watchpat300) and will be compared between both arms

    Time frame: First postoperative night

  23. Percentage of light sleep in total sleep time

    Percentage of light sleep will be measured by a home sleep study device (Watchpat300) and will be compared between both arms

    Time frame: First postoperative night

  24. Percentage of awake time

    Percentage of awake time will be measured by a home sleep study device (Watchpat300) and will be compared between both arms

    Time frame: First postoperative night

07

Study locations

1 site
  • Vitalys
    Elst, 6662 NC, Netherlands
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 18, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06432933
Lead sponsor
Rijnstate Hospital
Responsible party
Sponsor
First posted
May 29, 2024
Start date
Apr 9, 2024
Primary completion
Mar 21, 2025
Completion
Mar 21, 2025
Last update
Jul 18, 2025

Study contacts

Eric Hazebroek, Prof.dr.
principal investigator · Rijnstate Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion